Introduction

2021 Introduction

Permanent changes have emerged following the COVID-19 pandemic. The health industry has left behind traditional care models that were functional for years and is looking ahead to a new era of digitalization, patient centricity and a focus on health, rather than disease.

This transformation has called for the collaboration of Mexico’s public and private sectors. All industry stakeholders have united their strengths, boosting their capabilities, reach and quality to the benefit of the country’s large population. These operational shifts have demanded technology implementations at all levels of the production and distribution chain. As the digital transformation moves forward, readiness will define providers’ competitiveness in a new health market.

The sector also understands the value of innovation and investment in R&D, areas that Mexico is keen to explore and where it has great development potential. The pandemic also evidenced how poor health financing models can lead families into poverty. Mexico’s long-time health financing struggle were also in the spotlight as novel insurance models emerged. Efforts in this area are also complemented by the initiatives of large players in the medical devices and pharmaceutical industries that are moving toward value-based models to support health systems and patients.

Mexico Health Review 2021 will explore these and other emerging trends that the industry could explore to achieve sustainability and efficiency while moving toward a model based on prevention that aims for sustained health instead of focusing on curing diseases that could be prevented or better managed with the right care. This edition of Mexico Health Review outlines the opportunities, learning curves and excitement for the future of Mexico’s care providers, providing the latest insights directly from the people shaping the industry.